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Background: The increasing prevalence of treated end-stage renal disease and low transplant rates in Africa leads
to longer durations on dialysis. Dialysis should not only be aimed at prolonging lives but also improve quality of life
(QOL). Using mixed methods, we investigated the QOL of patients on chronic haemodialysis (HD) and peritoneal
dialysis (PD).
Methods: We conducted a cross-sectional study at Tygerberg Hospital in Cape Town, South Africa. All the PD
patients were being treated with continuous ambulatory peritoneal dialysis. The KDQOL-SF 1.3 questionnaire was
used for the quantitative phase of the study. Thereafter, focus-group interviews were conducted by an experienced
facilitator in groups of HD and PD patients. Electronic recordings were transcribed verbatim and analysed manually
to identify emerging themes.
Results: A total of 106 patients completed questionnaires and 36 of them participated in the focus group
interviews. There was no difference between PD and HD patients in the overall KDQOL-SF scores. PD patients
scored lower with regard to symptoms (P = 0.005), energy/fatigue (P = 0.025) and sleep (P = 0.023) but scored
higher for work status (P = 0.005) and dialysis staff encouragement (P = 0.019) than those on HD. Symptoms and
complications were verbalised more in the PD patients, with fear of peritonitis keeping some housebound. PD
patients were more limited by their treatment modality which impacted on body image, sexual function and
social interaction but there were less dietary and occupational limitations. Patients on each modality acknowledged
the support received from family and dialysis staff but highlighted the lack of support from government. PD patients
had little opportunity for interaction with one another and therefore enjoyed less support from fellow patients.
Conclusions: PD patients experienced a heavier symptom burden and greater limitations related to their dialysis
modality, especially with regards to social functioning. The mixed-methods approach helped to identify several issues
affecting quality of life which are amenable to intervention.Background
Chronic kidney disease (CKD) is an important public
health problem which is increasing in terms of inci-
dence and prevalence. The worldwide prevalence is
10–13% [1, 2] and similar estimates are reported for
Africa (13.9%) [3]. End-stage renal disease (ESRD) is a
serious complication of CKD and requires renal re-
placement therapy (RRT) in the form of haemodialysis* Correspondence: mrd@sun.ac.za
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Of the more than 1.8 million patients worldwide on
dialysis, less than 5% are in Africa where access to RRT
is dependent on very limited government support [4,
5]. The dialysis rates across Africa are less than 20 per
million population (pmp) as compared to a global
prevalence of 223 pmp. In Africa, 97% of dialysis
patients are on HD [6]. South Africa has a higher pro-
portion of patients on PD. According to recent registry
data 71.8% of patients receiving RRT are on HD and
13.5% on PD [7].le is distributed under the terms of the Creative Commons Attribution 4.0
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quality of life [5, 8]. Transplantation results in im-
proved survival, lower costs and better quality of life
[9–14] but transplant rates in Africa are very low, aver-
aging only 4 pmp [15] and decreasing. In South Africa,
the proportion of RRT patients with a functioning
transplant has decreased from 55.5% in 1994 to 14.7%
in 2014 [7, 16]. The low transplant rates and increasing
numbers of patients requiring RRT result in longer
durations on dialysis, emphasising the importance of
assessing and optimizing the quality of life of our pa-
tients on chronic dialysis.
Health-related quality of life (HRQOL) has become in-
creasingly important as an outcome measure of RRT.
The traditional focus on the improvement of survival
has recently shifted to include a much stronger emphasis
on quality of life [8]. HRQOL represents the impact of
the disease or its treatment on the subjective feelings of
patients about their physical, mental, spiritual, emo-
tional, social and functional wellbeing [17]. HRQOL
deteriorates as kidney function worsens [18] and is an
independent risk factor for mortality in dialysis patients
[19]. The Kidney Disease Quality of Life (KDQOL) ques-
tionnaire [20] has been validated for use as a disease-
specific measure of quality of life. It combines the SF-36
instrument with kidney disease specific items [21, 22].
Quality of life among dialysis patients has been shown
to be lower as compared to pre-dialysis CKD patients
[23], the general population [24] and other chronic dis-
eases like congestive heart failure, diabetes, depression
and even cancer [25].
In the large Dialysis Outcome and Practice Pattern
study (DOPPS) in the United States [26] poor scores in
the physical component of the HRQOL were associated
with increased mortality and increased risk of future
hospitalisation.
The quality of life of patients on PD has been re-
ported to be better than for those on HD in some stud-
ies [27–30] but others, including a systematic review
[14, 28, 31, 32], have reported no difference between
the two treatment modalities. PD patients tended to
have lower scores in the role-physical and bodily pain
domains whereas HD patients had lower scores in the
emotional component [33]. Low quality of life at the
initiation of RRT is associated with increased hospital-
isation and higher mortality, emphasizing the need for
early interventions [34, 35].
Very few studies have been conducted comparing the
quality of life of HD and PD patients in South Africa
[28, 36, 37]. A study in the Western Cape, South Africa,
reported low HRQOL in both dialysis modalities with no
difference between HD and PD [28]. Another South
African study [37] which included dialysis patients from
both the private and public healthcare sectors alsoreported compromised quality of life in both modalities
although HD patients were found to have increased vi-
tality and better physical component scores.
There are no qualitative data available from these
studies to provide a richer interpretation of the numbers
reported. We therefore sought to study the quality of life
of patients treated with PD and HD using a comparative
mixed methods approach. Focus group interviews have
the potential to generate rich data based on the synergy
of group interaction and allowed us to ascertain our pa-
tients’ perspectives about factors affecting their quality
of life.
Methods
We conducted a cross-sectional study involving both
qualitative and quantitative methods. Tygerberg Hospital
is a public-sector 1384-bed teaching hospital in Cape
Town, South Africa. The numbers of patients on RRT is
limited to approximately 65 patients on HD and 55 pa-
tients on PD due to resource constraints. Only patients
who are transplantable are accommodated and the renal
replacement programme operates on a PD-first policy as
there are limited numbers of haemodialysis slots avail-
able. A few patients are accommodated closer to their
homes at satellite HD units in the nearby towns of Paarl,
Worcester, Hermanus and Vredenburg.
All our HD patients receive three 4-hour, in-centre,
treatments per week. High-flux dialysers and bicarbonate-
based dialysate solutions are used. Continuous ambulatory
peritoneal dialysis (CAPD) using a twin-bag system is the
sole form of PD, with the majority of PD patients perform-
ing four 2-litre exchanges per day. None of our patients
have access to a cycler for automated PD because of the
substantially higher costs of this treatment option. Dialysis
access is achieved via arterio-venous fistulae or tunnelled
catheters for most HD patients. For the PD patients,
Tenckoff catheters are inserted at the bedside, or in the-
atre by the surgical team in cases where there are likely to
be intra-abdominal adhesions. All patients on chronic dia-
lysis have access to erythropoietin and intravenous iron as
required. Unfortunately, most patients present late and
there are usually few opportunities for pre-dialysis
counselling.
Dialysis patients were recruited from June 2015 and
March 2016 if they had been stable on a treatment mo-
dality for more than three months. Participants with
other chronic illnesses such as malignancy, chronic liver
disease or stroke were excluded from the study. Patients
admitted in the previous month for any acute illness
were also excluded. Participants completed a validated,
pre-tested, self-administered questionnaire, the KDQOL-
SF 1.3 [20]. This instrument includes 43 items which are
focused on the health-related concerns of patients with
renal disease on dialysis (Table 2, first column) and 36
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the KDQOL-SF 1.3 are transformed to a score ranging
from 0 to 100 with higher scores representing better per-
ceived QOL.
Data for quantitative analysis were captured using
REDCap [38] and analysed with Stata/SE 14 [39]. Data
were summarized as means ± standard deviations, or
medians and interquartile ranges if not normally distrib-
uted. The chi square and Fisher’s exact tests were used
for categorical variables. Student’s t test was used to
compare continuous variables, and the Wilcoxon sign
rank test when not normally distributed. A P-value of
<0.05 was considered statistically significant.
The qualitative phase of the study involved six hour-
long focus group interviews [40], each conducted by an
experienced registered nurse without any connection to
the RRT programme. The interviews included three
groups comprised of only HD patients and three groups
of only PD patients. Each group included approximately
six patients, with the participants in each group having
been purposively sampled to ensure variation based on
sex, race, language and dialysis vintage [41]. English and
Afrikaans1 were the languages used; the facilitator was
fluent in these languages. Prompts were used and lead-
ing questions avoided allowing participants the freedom
to express themselves.
The interviews continued until data saturation was
reached. Interviews were recorded electronically, tran-
scribed verbatim and then analysed using thematic ana-
lysis with a view to identifying recurring patterns in the
texts [42]. Accordingly, the transcripts were coded and
subsequently thematic labels assigned manually [41].Table 1 Baseline characteristics of study participants
Variable PD (n = 48)
Age (years) 36.1 ± 10.7
Female 27 (56.3)
Ethnicity
Mixed ancestry 34 (70.8)
Black 9 (18.8)
White 4 (8.3)
Duration on RRT (years) 2.2 (0.6–4.1)
Duration on modality (years) 1.1 (0.2–3.3)
Haemoglobin (g/dl) 8.8 ± 2.1
Albumin (g/l) 35.0 ± 5.7
Total calcium (mmol/l) 2.18 ± 0.3
Phosphate (mmol/l) 2.0 ± 0.8
PTH (pmol/l) 48.3 (25.4–130.7)
spKt/V
Data expressed as mean ± standard deviation, median (interquartile range) or as nu
Abbreviations: RRT renal replacement therapy, spKt/V single pool Kt/VResults
Quantitative phase
A total of 106 patients were recruited out of a total of 128
eligible dialysis patients. Eight patients could not be
reached, 2 declined to participate and the remainder did
not return their questionnaires, giving a response rate of
83.6%. Participants included 48 PD patients and 58 on HD.
Regarding the baseline characteristics (Table 1), the
mean age in the PD group was lower (36.1 vs. 42.8 years,
P = 0.001). Most of the participants were females and
their ethnicity was mostly mixed ancestry (“Coloured”)
[43], reflecting the population of the Western Cape. The
median duration on RRT was 2.2 years for PD patients
and 6.0 years for the HD patients (P < 0.001). Median
duration on the current dialysis modality was 1.1 years
and 3.2 years respectively (P = 0.003).
For the HD patients, dialysis access was achieved via
arterio-venous fistulae in 25 patients (41.4%), tunnelled
catheters in 28 (48.3%), temporary dialysis catheters in 4
and via arterio-venous grafts in 2 patients. Dialysis ad-
equacy in the HD patients was good with a mean single
pool Kt/V of 1.44 ± 0.29. Adequacy was not measured
routinely in the patients on PD. The HD patients had
higher mean haemoglobin and serum albumin concen-
trations, and lower serum phosphate concentrations
(Table 1). While we do not have complete data on peri-
tonitis, a retrospective review of the period of the study
revealed that peritonitis rates were high, exceeding 1 epi-
sode per patient per year.
Kidney-disease-targeted items (Table 2). Overall,
there was no difference between the groups. There were,
however, differences in the symptoms, work status andHD (n = 58) P
42.8 ± 9.8 0.001
41 (70.7) 0.123
42 (72.4) 0.72
12 (20.7)
4 (6.9)
6.0 (3.4–10.9) <0.001
3.2 (1.2–6.0) 0.003
10.5 ± 1.9 0.001
37.9 ± 3.9 0.004
2.19 ± 0.3 0.855
1.71 ± 0.8 0.044
43.0 (17.8–95.6) 0.198
1.44 ± 0.28
mber (percentage)
Table 2 Comparison of the KDQOL-SF 1.3 scores of the
kidney-disease-targeted items between PD and HD patients
Disease-targeted items PD (n = 48) HD (n = 58) P
Symptoms 63.8 ± 19.5 73.6 ± 15.6 0.005
Effects of kidney disease 60.9 ± 25.9 63.5 ± 25.0 0.601
Burden of kidney disease 42.8 ± 32.8 47.9 ± 33.4 0.460
Work status 41.7 ± 42.9 19.3 ± 32.4 0.005
Cognitive function 72.0 ± 18.9 77.9 ± 21.0 0.135
Quality of social interaction 68.1 ± 20.3 71.0 ± 17.7 0.433
Sexual function 71.1 ± 19.0 65.9 ± 33.1 0.516
Sleep 55.5 ± 16.1 62.9 ± 16.9 0.023
Social support 79.5 ± 24.4 82.2 ± 23.5 0.569
Dialysis staff encouragement 93.5 ± 11.8 86.4 ± 17.4 0.019
Patient satisfaction 72.9 ± 23.2 63.5 ± 26.4 0.056
Total 65.4 ± 13.7 65.1 ± 11.7 0.903
Data expressed as mean ± standard deviation or median (interquartile range)
Abbreviations: RRT renal replacement therapy
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and sleep, and scored higher for work status and dialysis
staff encouragement than those on HD.
For the generic core SF-36 items (Table 3), there was
also no difference between the groups. The HD group,
however, scored higher in the social functioning and en-
ergy/fatigue domains. Overall KDQOL-SF 36 1.3 scores
were not different for the two modalities.Qualitative phase
Participants in the focus group discussions
A total of 17 participants (11 females) on PD took part
in the focus group discussions. Their mean age was
39.4 years (range 21–64 years), with 2 black patients, 2
white patients and 13 who were of mixed ancestry. The
median duration on any form of RRT was 3.0 yearsTable 3 Comparison of the generic core 36-item health survey
of the KDQOL-SF36 1.3 questionnaire in PD and HD patients
SF-36 item health items PD (n = 48) HD (n = 58) P
Physical function 55.5 ± 21.7 54.7 ± 19.4 0.829
Role physical 25.5 ± 34.0 33.8 ± 38.5 0.314
Pain 61.6 ± 29.9 60.2 ± 29.5 0.811
General health 47.9 ± 22.3 48.7 ± 21.9 0.850
Emotional wellbeing 62.7 ± 19.7 68.6 ± 17.9 0.112
Role-emotional 49.6 ± 45.0 41.4 ± 41.6 0.362
Social function 54.9 ± 26.4 67.5 ± 22.2 0.009
Energy and fatigue 45.0 ± 18.0 52.2 ± 14.4 0.025
Total 50.5 ± 18.2 53.5 ± 17.4 0.386
Overall KDQOL-SF1.3 score 57.9 ± 14.3 59.3 ± 13.2 P = 0.612
Data expressed as mean ± standard deviation or median (interquartile range)(range 0.3–23.0 years) and the median duration on PD
was 1.6 years (range 0.3–8.7 years).
For the HD focus groups, there were 19 participants (11
females) with a mean age of 38.2 years (range 20–59 years).
They included 7 black patients and 12 of mixed ancestry.
All but one of the HD patients had previously been treated
with PD. The median duration on RRT was 6.8 years
(range 0.8–26.3 years) and the median duration on HD
was 2.8 years (range 0.5–13.8 years). Three patients had
had a previous kidney transplant.
The results of this phase of the study are discussed
below under the various themes which emerged during
the thematic analysis.
Symptoms and complications
Reported symptoms and complications included dialysis
access infection, insomnia, itching, decreased libido and
decreased sexual performance. With regards to dialysis
access, peritonitis was noted as a common complication
by the PD group while the HD patients did not verbalise
any vascular access issues. In fact, fear of developing
peritonitis kept some PD patients housebound, since
they were worried that they would get infected if they
did their exchanges outside their homes.
“When you wake up in the morning, the stomach is
like cramping …” (PD, male)
“It’s outside, going outside I have to worry about. The
temperature I have to worry about, the weather, how
cold, how wet, how windy, and everything.” (PD, female)
PD patients found it difficult to sleep at night while
the HD patients reported sleeping better than when they
were on PD. Itching was verbalised as a cause of the in-
somnia by some patients on PD. There were no com-
ments on itching in the HD group.
“You can’t help it. You don’t want to scratch, but it’s
itching.” (PD, female)
“In the beginning when I started on Haemo I could not
sleep at night, but it got better and now it is gone.”
(HD, female)
Both groups described decreased desire for sex, and
some of the male HD patients complained of erectile
dysfunction.
“I’m too weak for the girls. I can’t perform.” (HD, male)
Limitations
Patients verbalised treatment-related limitations involv-
ing their diet, occupations, social interactions, body
image and sexual life. The effect on body image was only
expressed in the PD group, and mainly among female
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did not find their abdomens with the visible peritoneal
dialysis catheter a pleasant sight.
“… you are not feeling like a person anymore. You
don’t want to undress in front of him …” (PD, female)
“… It’s [the catheter] not something you always want
to look at every day… It really, really limits you.”
(PD, female)
“You cannot, the way you had sex before, it’s not the
same anymore …if he starts touching me, then I think:
Oh God, the ‘pipe’, you know.” (PD, female)
Dietary restrictions were noted by both groups as one
of the key components that affected their quality of life.
HD patients seemed to be more aware of their restric-
tions than their PD counterparts. Both groups reported
limiting their water intake by sucking on ice to quench
their thirst.
Just for me not to be able to drink as much as I love to
drink, that’s the worst thing for me, really, because I
love tea.” (PD, female)
“We must drink ice, not water, but crushed ice”
(HD, Female)
Patients on both modalities were limited socially.
Some PD patients stayed at home to do their scheduled
bag exchanges and those who did go out would rush
home in time for their next exchange. Young PD pa-
tients found it difficult to start and maintain relation-
ships due to their kidney disease and had difficulty
explaining themselves to prospective partners. HD pa-
tients mentioned that they could not travel away from
their dialysis centres to visit family, attend key events
such as funerals or go on vacations to places where there
were no HD facilities.
“… you can’t go with them because they won’t come
back in time for you to do your exchange. So I rather
stay at home…” (PD, female)
“It does limit you. It does limit you to your house.”
(PD, female)
“You can’t even go on holidays because the hospitals
in Eastern Cape2, they don’t have the support.”
(HD, male)
Another major limitation that was raised related to
their occupations. While PD patients are usually consid-
ered to be more independent and able to work, most
found it difficult to get employment, or to do their ex-
changes at work. Those who had a job felt that theywere not seen as very productive by their employers.
They stated that their employers were told by the doc-
tors that PD patients are fit to work, and therefore ex-
pected a normal work performance from them despite
the fact that some were still adjusting to PD and were
often feeling very tired. HD patients generally did not
work due to the need for hospital-based dialysis sessions
three times a week. A few who managed to work on the
non-dialysis days encouraged others to do the same.
“…. you don’t get a job if you are on PD. People don’t
want to employ us….” (PD, male)
“they don’t accommodate us as kidney patients in the
workplace… sometimes it gets to the point where I just
feel I’m really not doing PD today, it’s too much.”
(PD, female)
“… it’s better when you are working. Now we can’t
work.” (HD, female)
Support
Patients found support from family, staff and fellow pa-
tients helpful in coping with their disease and maintain-
ing their quality of life. Patients in both groups
acknowledged that they were privileged to have good
family support. Some HD patients, however, did not
find the family supportive when it came to discussing
issues around kidney donation. They blamed ignorance
about kidney disease and inadequate education on
organ transplantation as the main reasons why family
members refused to be organ donors. Furthermore,
they were of the opinion that the government did not
support kidney patients as well as they supported pa-
tients with infectious diseases like HIV/AIDS and TB.
“My family has been supportive since day one. ….my
whole family started eating healthy.” (PD, female)
“…because now you want this kidney, they just turn
their backs to you … the friends are running away.”
(HD, female)
“Everyone has become obsessed with HIV. We know
it is on everyone’s tongues. But nobody asked about
kidney failure.” (HD, female)
PD patients did not get much support from fellow pa-
tients since they usually had little interaction and did
not know each other. Dialysis exchanges were done at
home and they visited the hospital infrequently. They re-
ported finding the focus group discussions very helpful
and appreciated the opportunity to share experiences
and ideas with each other. The following example illus-
trates this type of interaction.
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(PD female)
A colleague answers: “The itchiness, yes. But it’s not
the pills. It’s the build-up of urea.” (PD male)
HD patients, on the other hand, visited the hospital
three times a week, often sharing the same hospital
transport, and enjoyed a lot of support from fellow
patients.
“I was weak when I came here, and the support I got
from the patients from the transport… I get strong.”
(HD, female)
“…We speak the same language and encourage each
other. This is important to us as patients and our
lives.” (HD, female)
The support received from the Renal Unit staff was
described as good by patients on both modalities. This
helped them to cope with their disease. Some PD pa-
tients complained that the staff were unhappy when they
came in after hours with complications.
“…they are professional and all, but they are like
family.” (HD, female)
“They’re never miserable, they’re never moody,
and even if they have issues at home they don’t bring
it here.” (PD, female)
Discussion
The use of focus group interviews allowed us to explore
patients’ perspectives and provided a rich source of
qualitative data to illuminate the scores obtained from
the questionnaires. We found no difference in the over-
all quality of life between HD and PD patients as mea-
sured by KDQOL 1.3 scoring. This finding is similar to
that reported by other studies, including two conducted
in South Africa [14, 28, 31, 32, 37]. Our overall QOL
scores were somewhat lower than those reported from
another public sector hospital in Cape Town [28] and
comparable to a South African study which included pa-
tients from both private and public healthcare sectors
[37].
Regarding the domains within the KDQOL 1.3 ques-
tionnaire, we found differences in the scores for specific
domains between patients on the two dialysis modal-
ities. PD patients had lower scores for symptoms, en-
ergy/fatigue, sleep and social function but better scores
for work status and dialysis staff encouragement. The
data which emerged from the focus interviews have
shed more light on some of these findings.
The patients on PD verbalised more symptoms related
to the ESRD and the complications of their dialysismodality. Peritonitis and catheter exit site infection was
a common concern while access infections were not
mentioned by the HD patients at all. Pruritus was a not-
able symptom which affected sleep in the PD patients
but was not mentioned by the HD patients. Pruritus is
common in dialysis patients and is associated with poor
sleep, poor QOL and increased mortality [44]. Sexual
dysfunction, including decreased libido and erectile dys-
function, were reported by patients on both modalities.
The presence of the Tenckhoff catheter protruding from
the abdomen negatively affected the body image and
sexual function of the PD patients. HD patients reported
symptoms suggestive of intradialytic hypotension and
orthostatic hypotension after dialysis. These symptoms
are also predictive of increased mortality [45]. Longer
dialysis vintage may be associated with better QOL [46].
Our PD patients had a lower vintage and their symptom
burden may reflect the initial difficulties in adjusting to
life on dialysis, lower haemoglobin and albumin concen-
trations, as well as the occurrence of complications such
as peritonitis and catheter exit site infection.
The lower social function score in the PD group was
contrary to our expectation that PD patients would be
more independent and therefore more likely to enjoy an
active social life. This surprising finding was clarified in
the focus group interviews where it became clear that
the fear of developing peritonitis caused many patients
to sacrifice social interactions to be able do their PD ex-
changes at home and at the specified times. Some felt
that their home was the only safe place to do their ex-
changes. HD patients felt that their social interactions
were limited by the need to remain close to their dialysis
centres.
PD patients had better work status scores but never-
theless reported difficulties in finding employment and
difficulties in doing bag exchanges while at work. They
perceived their doctors and nurses as having unrealistic
expectations of their ability to find and maintain em-
ployment. The treatment modality was considered to
provide flexibility of lifestyle and leave them relatively
independent but, in reality, this was mostly not the case.
Their high symptom burden and the lack of support by
employers in terms of providing time and space to do
their bag exchanges made working very difficult. In con-
trast, the HD patients were generally understood to be
unable to work due to the many hours per week spent
on dialysis and travelling between their homes and treat-
ment centres. Their doctors were more likely to support
their applications for government social grants (“disabil-
ity grants”). This discrepancy in the access to social
grants was a major concern for the PD patients.
The dialysis staff encouragement domain had the high-
est scores for both groups of patients, although PD pa-
tients had the higher scores. Dialysis staff were described
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their quality of life. The support of their families, fellow
patients and also government support was verbalised as
being extremely important. Social support exerts a
strong independent influence on subjective and objective
QOL [47]. PD patients called for the establishment of a
patient support group and better financial support.
Reid et al. [48] conducted a systematic review to
synthesize the experiences of patients on haemodialysis
and identified four broad themes which emerged from
the included studies: a new dialysis-dependent self, a re-
stricted life, regaining control, and relationships with
health professionals. Our findings can be mapped to all
of these themes which could be used as a framework to
consider interventions for improving the experiences of
patients on chronic dialysis. Of note is that in our study
relatively little data emerged on regaining control, pos-
sibly indicating an area where we should focus our own
interventions.
The findings of the study have caused us to review
several aspects of our management of patients on
chronic dialysis. In view of our strict PD-first policy, it is
especially important that we do more for our PD pa-
tients to optimise their dialysis, facilitate their social
functioning and improve the support that they receive.
This includes educating them that doing occasional ex-
changes early or late when they have important social
events will not cause long-term problems. It also in-
cludes more readily motivating for government grants
for those who are not well enough to work or cannot
find work, having our social worker increase her efforts
to enlist the support of employers and arranging regular
meetings of support groups which include both HD and
PD patients.
We have recognised that the increased symptom
burden and the sub-optimal laboratory data of our PD
patients may be due, at least in part, to chronic under-
dialysis and high rates of peritonitis. This has
prompted us to start a quality improvement project
which will be focused on reducing peritonitis rates,
monitoring the adequacy of dialysis and improving an-
aemia management. Expedited transplantation or a
switch to haemodialysis will be considered more read-
ily for patients who are clearly not thriving on PD.
Our study has several limitations. It is a single-centre,
cross-sectional study with relatively small numbers of
patients. The experiences of our patients may not be the
same as those of patients managed in well-resourced set-
tings where there is broad access to RRT and where
patient choice plays an important role in determining
the dialysis modality. The findings we have reported may
be especially relevant to RRT programmes in resource-
limited settings where a PD-first policy is being followed
and where the availability of haemodialysis is limited.Another potential limitation relates to the selection of
our study participants. The patients in the focus groups
were not selected randomly, but purposively so as to en-
sure the inclusion of a variety of participants, and opin-
ions, in terms of sex, ethnicity, language and dialysis
vintage. Having both males and females in a focus group,
as was the case in this study, could potentially inhibit
discussion about issues such as sexual dysfunction. How-
ever, our facilitator was struck by the open discussion
around sexual function and did not get the impression
that the participants were inhibited at all.
Conclusions
Our study has found that patients on PD were more
symptomatic and experienced more treatment-related
limitations than those on HD. In seeking to study what
influences the quality of life of our dialysis patients we
need to look beyond just the clinical issues and under-
stand their real contexts. By applying qualitative research
methods, clinicians may gain a deeper and more
complete understanding of their patients’ experiences
and help to identify issues affecting quality of life which
may be amenable to intervention.
Endnotes
1Afrikaans is one of South Africa’s 11 official languages
and the most spoken language in the province where the
study was conducted.
2The Eastern Cape is an under-resourced province
in South Africa, especially as concerns dialysis and
transplantation services.
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